- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05596188
Anxiety Before Non-cardiac Surgery in Adults
May 29, 2023 updated by: RenJi Hospital
Status and Independent Risk Factors of Preoperative Anxiety in Adults Undergoing Non-cardiac Surgery: a Cross-sectional Study
Adult patients undergoing elective non-cardiac surgery were enrolled.
Anxiety before the operation was evaluated by The State Anxiety Inventory (S-AI).
Logistics regression would be used for identifying the independent factors of preoperative anxiety and prediction model would be established.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
424
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Min Chen
- Phone Number: +862168383702
- Email: chenmin@renji.com
Study Contact Backup
- Name: Siyuan Sun
- Email: sunsiyuan@renji.com
Study Locations
-
-
-
Shanghai, China, 200127
- Recruiting
- RenJi Hospital
-
Contact:
- Min Chen
- Phone Number: +862168383702
- Email: chenmin@renji.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
patients who met the eligibilty criteria for elective surgery under general anesthesia.
Description
Inclusion Criteria:
- patients undergoing elective with general anesthesia surgery (gynecologic oncology, general surgery, orthopedics and urinary);
- The estimated operation time is more than 2 hours. 3)18≤ age ≤ 80;
4)be able to communicate normally in daily life, without serious hearing and visual impairment; 5)ASA:I-II; 6)sign informed consent and volunteer to participate in this study.
Exclusion Criteria:
- Having a history of brain diseases, such as stroke, epilepsy, psychosis other history of neuropsychiatry.
- Patients with serious diseases of heart, liver, lung, kidney or other organs.
- Having a definite diagnosis of cognitive impairment, such as Alzheimer's disease;
- Those who use sedatives before evaluation in this study;
- Drug addicts;
- Alcoholics;
- pregnant women;
- participated in other clinical trials as a subject in the past 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Independent risk factors of preoperative anxiety and establishment of prediction model
Time Frame: From the 1 day before surgery to 7 days after surgery or discharge, whichever came first
|
To identify the independent factors related to preoperative anxiety, which would be analyzed by Logistic regression according to anxiety or not before surgery evaluated by the State anxiety inventory(20-80,lower is better) .
Meanwhile, the prediction model of preoperative anxiety would be established based on independent factors.
|
From the 1 day before surgery to 7 days after surgery or discharge, whichever came first
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of preoperative anxiety
Time Frame: The 1 day before surgery
|
The State anxiety inventory (20-80,lower is better) was used to investigate the incidence of Preoperative anxiety
|
The 1 day before surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2022
Primary Completion (Estimated)
October 17, 2023
Study Completion (Estimated)
March 31, 2024
Study Registration Dates
First Submitted
October 23, 2022
First Submitted That Met QC Criteria
October 26, 2022
First Posted (Actual)
October 27, 2022
Study Record Updates
Last Update Posted (Actual)
May 31, 2023
Last Update Submitted That Met QC Criteria
May 29, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SSY04070224
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Prostate Cancer
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Roswell Park Cancer InstituteRecruitingObesity | Overweight | Cancer Survivor | Prostate Adenocarcinoma | Stage I Prostate Cancer | Stage II Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage A Prostate Cancer | Stage... and other conditionsUnited States
-
Mayo ClinicNot yet recruitingProstate Cancer | Metastatic Prostate Cancer | Prostate Adenocarcinoma | Advanced Prostate Cancer | Localized Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Adenocarcinoma of the Prostate | Metastatic Prostate Adenocarcinoma | Advanced Prostate Adenocarcinoma | Recurrent Prostate Adenocarcinoma | Castration-Sensitive Prostate Cancer and other conditionsUnited States
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
University of Southern CaliforniaNational Cancer Institute (NCI); SanofiTerminatedDiarrhea | Recurrent Prostate Cancer | Hormone-resistant Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Cancer Institute and Hospital, Chinese Academy...RecruitingProstate Cancer Castration-resistant Prostate CancerChina
-
Ohio State University Comprehensive Cancer CenterRiverside Methodist HospitalCompletedStage I Prostate Cancer | Stage III Prostate Cancer | Stage IV Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
University of California, IrvineCompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Adenocarcinoma of the Prostate | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States
-
Jonsson Comprehensive Cancer CenterProgenics Pharmaceuticals, Inc.TerminatedRandomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...United States
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Stage I Prostate Cancer | Stage III Prostate Cancer | Stage IIA Prostate Cancer | Stage IIB Prostate CancerUnited States